Biotechnology · Healthcare
CEO
2024-04-16–present
Equibles does not estimate personal net worth.
Ed Pershing is recorded as CEO at Provectus Biopharmaceuticals, Inc. (PVCT) since April 16, 2024. Provectus Biopharmaceuticals, Inc. reported in an 8-K filed April 16, 2024 that Ed Pershing was appointed Chief Executive Officer ("CEO"). Provectus Biopharmaceuticals, Inc. reported in an 8-K filed April 16, 2024 that Ed Pershing was appointed Chief Executive Officer, effective April 16, 2024. Provectus Biopharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Provectus Biopharmaceuticals, Inc. includes Dominic Rodrigues (CEO), Edward Pershing (CEO), Heather Raines (CFO) and 2 others.
“The Company's Board of Directors (the "Board") has appointed Ed Pershing as Chief Executive Officer ("CEO") and Dominic Rodrigues as President.”
“On April 10, 2024, the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) appointed Ed Pershing as the Company’s Chief Executive Officer effective April 16, 2024.”
2024-04-16–present
Biotechnology · Healthcare
CEO
2024-04-16–present